Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007, Article ID 93416, 9 pages
http://dx.doi.org/10.1155/2007/93416
Research Article

Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines

Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello 30, Turin 10125, Italy

Received 21 June 2006; Revised 20 December 2006; Accepted 22 January 2007

Academic Editor: G. Youssef

Copyright © 2007 G. Martinasso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kawamata, M. Tachibana, T. Fujimori, and Y. Imai, “Differentiation-inducing therapy for solid tumors,” Current Pharmaceutical Design, vol. 12, no. 3, pp. 379–385, 2006. View at Publisher · View at Google Scholar
  2. G. Chinetti, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation,” Inflammation Research, vol. 49, no. 10, pp. 497–505, 2000. View at Publisher · View at Google Scholar
  3. G. D. Girnun, W. M. Smith, S. Drori et al., “APC-dependent suppression of colon carcinogenesis by PPAR?,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13771–13776, 2002. View at Publisher · View at Google Scholar
  4. R. A. Gupta and R. N. DuBois, “Controversy: PPARγ as a target for treatment of colorectal cancer,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 283, no. 2, pp. G266–G269, 2002. View at Google Scholar
  5. A. Bernando and L. Minghetti, “PPAR-γ agonists as regulators of microglial activation and brain inflammation,” Current Pharmaceutical Design, vol. 12, no. 1, pp. 93–109, 2006. View at Publisher · View at Google Scholar
  6. R. Kostadinova, W. Wahli, and L. Michalik, “PPARs in diseases: control mechanisms of inflammation,” Current Medicinal Chemistry, vol. 12, no. 25, pp. 2995–3009, 2005. View at Publisher · View at Google Scholar
  7. T. Wang, J. Xu, X. Yu, R. Yang, and Z. C. Han, “Peroxisome proliferator-activated receptor γ in malignant diseases,” Critical Reviews in Oncology/Hematology, vol. 58, no. 1, pp. 1–14, 2006. View at Publisher · View at Google Scholar
  8. K. Yang, K.-H. Fan, S. A. Lamprecht et al., “Peroxisome proliferator-activated receptor ? agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in Apc1638 N/+ Mlh1+/- double mutant mice,” International Journal of Cancer, vol. 116, no. 4, pp. 495–499, 2005. View at Publisher · View at Google Scholar
  9. M. Lehrke and M. A. Lazar, “The many faces of PPARγ,” Cell, vol. 123, no. 6, pp. 993–999, 2005. View at Publisher · View at Google Scholar
  10. R. Grau, C. Punzón, M. Fresno, and M. A. Iñiguez, “Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1,” Biochemical Journal, vol. 395, no. 1, pp. 81–88, 2006. View at Publisher · View at Google Scholar
  11. M. Grabacka, P. M. Plonka, K. Urbanska, and K. Reiss, “Peroxisome proliferator-activated receptor α activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt,” Clinical Cancer Research, vol. 12, no. 10, pp. 3028–3036, 2006. View at Publisher · View at Google Scholar
  12. N. Strakova, J. Ehrmann, J. Bartos, J. Malikova, J. Dolezel, and Z. Kolar, “Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors,” Neoplasma, vol. 52, no. 2, pp. 126–136, 2005. View at Google Scholar
  13. B. P. Kota, T. H.-W. Huang, and B. D. Roufogalis, “An overview on biological mechanisms of PPARs,” Pharmacological Research, vol. 51, no. 2, pp. 85–94, 2005. View at Publisher · View at Google Scholar
  14. R. Cunard, “The potential use of PPARα agonists as immunosuppressive agents,” Current Opinion in Investigational Drugs, vol. 6, no. 5, pp. 467–472, 2005. View at Google Scholar
  15. G. Martinasso, M. Maggiora, A. Trombetta, R. A. Canuto, and G. Muzio, “Effects of di(2-ethylhexyl) phthalate, a widely used peroxisome proliferator and plasticizer, on cell growth in the human keratinocyte cell line NCTC 2544,” Journal of Toxicology and Environmental Health, Part A, vol. 69, no. 5, pp. 353–365, 2006. View at Publisher · View at Google Scholar
  16. A. D. Burdick, D. J. Kim, M. A. Peraza, F. J. Gonzalez, and J. M. Peters, “The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation,” Cellular Signalling, vol. 18, no. 1, pp. 9–20, 2006. View at Publisher · View at Google Scholar
  17. H. Sampath and J. M. Ntambi, “Polyunsaturated fatty acid regulation of genes of lipid metabolism,” Annual Review of Nutrition, vol. 25, pp. 317–340, 2005. View at Publisher · View at Google Scholar
  18. M. Maggiora, M. Bologna, M. P. Cerù et al., “An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines,” International Journal of Cancer, vol. 112, no. 6, pp. 909–919, 2004. View at Publisher · View at Google Scholar
  19. G. Muzio, A. Trombetta, M. Maggiora et al., “Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression,” Free Radical Biology and Medicine, vol. 40, no. 11, pp. 1929–1938, 2006. View at Publisher · View at Google Scholar
  20. G. Muzio, G. Martinasso, A. Trombetta, D. Di Simone, R. A. Canuto, and M. Maggiora, “HMG-CoA reductase and PPARα are involved in clofibrate-induced apoptosis in human keratinocytes,” Apoptosis, vol. 11, no. 2, pp. 265–275, 2006. View at Publisher · View at Google Scholar
  21. V. G. Keshamouni, R. C. Reddy, D. A. Arenberg et al., “Peroxisome proliferator-activated receptor-? activation inhibits tumor progression in non-small-cell lung cancer,” Oncogene, vol. 23, no. 1, pp. 100–108, 2004. View at Publisher · View at Google Scholar
  22. G. Muzio, M. Maggiora, A. Trombetta et al., “Mechanisms involved in growth inhibition induced by clofibrate in hepatoma cells,” Toxicology, vol. 187, no. 2-3, pp. 149–159, 2003. View at Publisher · View at Google Scholar
  23. R. A. Canuto, M. Maggiora, A. Trombetta, G. Martinasso, and G. Muzio, “Aldehyde dehydrogenase 3 expression is decreased by clofibrate via PPAR gamma induction in JM2 rat hepatoma cell line,” Chemico-Biological Interactions, vol. 143-144, pp. 29–35, 2003. View at Publisher · View at Google Scholar
  24. R. A. Canuto, M. Ferro, R. A. Salvo et al., “Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells,” Biochemical Journal, vol. 357, no. 3, pp. 811–818, 2001. View at Publisher · View at Google Scholar
  25. J. A. Brockman, R. A. Gupta, and R. N. DuBois, “Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells,” Gastroenterology, vol. 115, no. 5, pp. 1049–1055, 1998. View at Publisher · View at Google Scholar
  26. R. A. Gupta, J. A. Brockman, P. Sarraf, T. M. Willson, and R. N. DuBois, “Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells,” Journal of Biological Chemistry, vol. 276, no. 32, pp. 29681–29687, 2001. View at Publisher · View at Google Scholar
  27. S. Ulrich, S. M. Loitsch, O. Rau et al., “Peroxisome proliferator-activated receptor ? as a molecular target of resveratrol-induced modulation of polyamine metabolism,” Cancer Research, vol. 66, no. 14, pp. 7348–7354, 2006. View at Publisher · View at Google Scholar
  28. M. Mutoh, N. Niho, and K. Wakabayashi, “Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice,” Biological Chemistry., vol. 387, no. 4, pp. 381–385, 2006. View at Publisher · View at Google Scholar
  29. M.-Y. Li, T. W. Lee, A. P. C. Yim, and G. G. Chen, “Function of PPARγ and its ligands in lung cancer,” Critical Reviews in Clinical Laboratory Sciences, vol. 43, no. 2, pp. 183–202, 2006. View at Publisher · View at Google Scholar
  30. T.-H. Chang and E. Szabo, “Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer,” Cancer Research, vol. 60, no. 4, pp. 1129–1138, 2000. View at Google Scholar
  31. M. W. Matthiessen, G. Pedersen, T. Albrektsen, S. Adamsen, J. Fleckner, and J. Brynskov, “Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas,” Scandinavian Journal of Gastroenterology, vol. 40, no. 2, pp. 198–205, 2005. View at Publisher · View at Google Scholar
  32. N. Strakova, J. Ehrmann, J. Bartos, J. Malikova, J. Dolezel, and Z. Kolar, “Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors,” Neoplasma, vol. 52, no. 2, pp. 126–136, 2005. View at Google Scholar
  33. M.-C. Clemencet, G. Muzio, A. Trombetta et al., “Differences in cell proliferation in rodent and human hepatic derived cell lines exposed to ciprofibrate,” Cancer Letters, vol. 222, no. 2, pp. 217–226, 2005. View at Publisher · View at Google Scholar
  34. P. Zahradka, B. Wright, M. Fuerst, N. Yurkova, K. Molnar, and C. G. Taylor, “Peroxisome proliferator-activated receptor α and γ ligands differentially affect smooth muscle cell proliferation and migration,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 2, pp. 651–659, 2006. View at Publisher · View at Google Scholar
  35. R. A. Roberts, S. Chevalier, S. C. Hasmall, N. H. James, S. C. Cosulich, and N. Macdonald, “PPARα and the regulation of cell division and apoptosis,” Toxicology, vol. 181-182, pp. 167–170, 2002. View at Publisher · View at Google Scholar
  36. J. E. Klaunig, M. A. Babich, K. P. Baetcke et al., “PPARa agonist-induced rodent tumors: modes of action and human relevance,” Critical Reviews in Toxicology, vol. 33, no. 6, pp. 655–780, 2003. View at Google Scholar
  37. G. Icre, W. Wahli, and L. Michalik, “Functions of the peroxisome proliferator-activated receptor (PPAR) α and β in skin homeostasis, epithelial repair, and morphogenesis,” Journal of Investigative Dermatology, vol. 126, pp. 30–35, 2006. View at Publisher · View at Google Scholar